N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide
C43H42ClN11O4S — CID 171071625
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide
N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide (PubChem CID 171071625) has the molecular formula C43H42ClN11O4S and a molecular weight of 844.40 g/mol. Its IUPAC name is N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide |
|---|---|
| PubChem CID | 171071625 |
| Molecular Formula | C43H42ClN11O4S |
| Molecular Weight | 844.40 g/mol |
| Exact Mass | 843.28 |
| IUPAC Name | N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[[[2-[N-methyl-4-[(9S)-4,5,13-trimethyl-9-(1,3-oxazol-2-ylmethyl)-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-7-yl]anilino]acetyl]amino]methyl]pyridazine-3-carboxamide |
| SMILES | Cc1sc2c(c1C)C(c1ccc(N(C)CC(=O)NCc3ccc(C(=O)NC4CCC(Oc5ccc(C#N)c(Cl)c5)CC4)nn3)cc1)=N[C@@H](Cc1ncco1)c1nnc(C)n1-2 |
| InChI | InChI=1S/C43H42ClN11O4S/c1-24-25(2)60-43-39(24)40(49-36(20-38-46-17-18-58-38)41-53-50-26(3)55(41)43)27-5-11-31(12-6-27)54(4)23-37(56)47-22-30-10-16-35(52-51-30)42(57)48-29-8-14-32(15-9-29)59-33-13-7-28(21-45)34(44)19-33/h5-7,10-13,16-19,29,32,36H,8-9,14-15,20,22-23H2,1-4H3,(H,47,56)(H,48,57)/t29?,32?,36-/m0/s1 |
| InChIKey | POBJNJNSBDTFAS-POEIKPMDSA-N |
| XLogP | 6.56 |
| TPSA | 189.34 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 844.40 |
| LogP ≤ 5 | 6.56 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171071625 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.